These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 26514400)
1. Is there a role for neurotrophic factors and their receptors in augmenting the neuroprotective effect of (-)-epigallocatechin-3-gallate treatment of sciatic nerve crush injury? Renno WM; Khan KM; Benov L Neuropharmacology; 2016 Mar; 102():1-20. PubMed ID: 26514400 [TBL] [Abstract][Full Text] [Related]
2. Possible role of antioxidative capacity of (-)-epigallocatechin-3-gallate treatment in morphological and neurobehavioral recovery after sciatic nerve crush injury. Renno WM; Benov L; Khan KM J Neurosurg Spine; 2017 Nov; 27(5):593-613. PubMed ID: 28777065 [TBL] [Abstract][Full Text] [Related]
3. (-)-Epigallocatechin-3-gallate modulates spinal cord neuronal degeneration by enhancing growth-associated protein 43, B-cell lymphoma 2, and decreasing B-cell lymphoma 2-associated x protein expression after sciatic nerve crush injury. Renno WM; Al-Maghrebi M; Rao MS; Khraishah H J Neurotrauma; 2015 Feb; 32(3):170-84. PubMed ID: 25025489 [TBL] [Abstract][Full Text] [Related]
20. An experimental comparison of the effects of propolis, curcumin, and methylprednisolone on crush injuries of the sciatic nerve. Yüce S; Cemal Gökçe E; Işkdemir A; Koç ER; Cemil DB; Gökçe A; Sargon MF Ann Plast Surg; 2015 Jun; 74(6):684-92. PubMed ID: 24317243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]